Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04187768 · ClinicalTrials.gov registry record
Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung Cancer
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 29
- Enrollment target
NCT04187768 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 29 participants.
The verdict
NCT04187768 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
This is a blood collection study being conducted to better understand and describe the immunological blood profile changes in patients with advanced non small cell lung cancer undergoing treatment with checkpoint inhibitor therapy. Blood will be collected from healthy volunteers and patients with non small cell lung cancer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2019-11-26 |
| Est. Completion | 2022-06-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04187768
The ClinicalTrials.gov registry entry for NCT04187768 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04187768 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04187768 about?
NCT04187768 is a clinical study titled "Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung Cancer". This is a blood collection study being conducted to better understand and describe the immunological blood profile changes in patients with advanced non small cell lung cancer undergoing treatment with checkpoint inhibitor therapy. Blood will be collected from healthy volunteers and patients with no...
What is the current status of trial NCT04187768?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2019-11-26. Estimated completion is 2022-06-13.
Who is sponsoring clinical trial NCT04187768?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.